{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:32:04Z","timestamp":1793277124683,"version":"4.5.0"},"reference-count":484,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2022,4,20]]},"abstract":"<jats:p>Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people globally and can cause severe and potentially fatal disease, including adult T-cell leukemia\/lymphoma (ATL) and HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). The burden of HTLV-1 infection appears to be geographically concentrated, with high prevalence in discrete regions and populations.<\/jats:p>","DOI":"10.1128\/cmr.00078-21","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T21:34:11Z","timestamp":1645652051000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":70,"title":["Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection"],"prefix":"10.1128","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-3592","authenticated-orcid":true,"given":"Nicolas","family":"Legrand","sequence":"first","affiliation":[{"name":"Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skye","family":"McGregor","sequence":"additional","affiliation":[{"name":"Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena","family":"Bull","sequence":"additional","affiliation":[{"name":"Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Bajis","sequence":"additional","affiliation":[{"name":"Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braulio Mark","family":"Valencia","sequence":"additional","affiliation":[{"name":"Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Ronnachit","sequence":"additional","affiliation":[{"name":"Royal Prince Alfred Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Einsiedel","sequence":"additional","affiliation":[{"name":"Central Australian Health Service, Alice Springs, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Gessain","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Epidemiology and Physiopathology of Oncogenic Viruses Unit, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kaldor","sequence":"additional","affiliation":[{"name":"Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Martinello","sequence":"additional","affiliation":[{"name":"Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00388"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.8.2534"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.17.5402"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/294770a0"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6476"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(85)92734-5"},{"key":"e_1_3_2_8_2","volume-title":"Human T-lymphotropic virus type 1: technical report.","author":"World Health Organization.","year":"2021","unstructured":"World Health Organization. 2021. Human T-lymphotropic virus type 1: technical report. License CC BY-NC-SA 3.0 IGO. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_9_2","volume-title":"Public health impact and implications for future actions: WHO global consultation on the human T-lymphotropic virus type 1, Tokyo, Japan, 13\u201315 November 2019.","author":"World Health Organization.","year":"2021","unstructured":"World Health Organization. 2021. Public health impact and implications for future actions: WHO global consultation on the human T-lymphotropic virus type 1, Tokyo, Japan, 13\u201315 November 2019. https:\/\/apps.who.int\/iris\/handle\/10665\/339886. License CC BY-NC-SA 3.0 IGO. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V50.3.481.481"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415"},{"key":"e_1_3_2_12_2","volume-title":"Geographical distribution of areas with a high prevalence of HTLV-1 infection.","author":"European Centre for Disease Prevention and Control.","year":"2015","unstructured":"European Centre for Disease Prevention and Control. 2015. Geographical distribution of areas with a high prevalence of HTLV-1 infection. ECDC, Stockholm, Sweden."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ145"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25239"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2013.814631"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23181"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-017-0693-9"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.5539\/gjhs.v6n5p99"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.07.004"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.12-0289"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21027"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-12-S1-O3"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-11-28"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/08892220050042828"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24428"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1992.8.651"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20000815)87:4<534::AID-IJC12>3.0.CO;2-M"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.5.2020-2026.2004"},{"key":"e_1_3_2_29_2","first-page":"1230","article-title":"Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians","volume":"5","author":"Allain JP","year":"1992","unstructured":"Allain JP, Hodges W, Einstein MH, Geisler J, Neilly C, Delaney S, Hodges B, Lee H. 1992. Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians. J Acquir Immune Defic Syndr (1988) 5:1230\u20131236.","journal-title":"J Acquir Immune Defic Syndr (1988)"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115824"},{"key":"e_1_3_2_31_2","first-page":"404","article-title":"Screening for HTLV-I in healthy blood donors in Trinidad and Tobago","volume":"42","author":"Daisley H","year":"1991","unstructured":"Daisley H, Charles W, Landeau P, Jackman L, Batson M, Gomez-Adams K. 1991. Screening for HTLV-I in healthy blood donors in Trinidad and Tobago. Trop Med Parasitol 42:404\u2013406.","journal-title":"Trop Med Parasitol"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39060639.x"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005278"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.61.85"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.3.649"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/519167"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw009"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/try039"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006832"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199503010-00016"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15838"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.00285"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb137694.x"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1988.tb120516.x"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832403e8"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200010010-00010"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199708010-00014"},{"key":"e_1_3_2_48_2","first-page":"324","article-title":"Evidence of HTLV-II infection in Guinea, West Africa","volume":"6","author":"Gessain A","year":"1993","unstructured":"Gessain A, Fretz C, Koulibaly M, Boudret ML, Bah A, Raphael M, de The G, Fournel JJ. 1993. Evidence of HTLV-II infection in Guinea, West Africa. J Acquir Immune Defic Syndr 6:324\u2013325.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.3.363"},{"key":"e_1_3_2_50_2","first-page":"31","article-title":"Seroprevalence of human T-cell lymphoma\/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria","volume":"6","author":"Okoye AE","year":"2015","unstructured":"Okoye AE, Ibegbulam OG, Onoh RC, Ugwu NI, Anigbo CS, Nonyelu CE. 2015. Seroprevalence of human T-cell lymphoma\/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria. J Blood Med 6:31\u201336.","journal-title":"J Blood Med"},{"key":"e_1_3_2_51_2","first-page":"130","article-title":"Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria","volume":"44","author":"Analo HI","year":"1998","unstructured":"Analo HI, Akanmu AS, Akinsete I, Njoku OS, Okany CC. 1998. Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria. Cent Afr J Med 44:130\u2013134.","journal-title":"Cent Afr J Med"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2014.17.301.4075"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/24.1.198"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1991.7.447"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46426-0"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.4.1550-1554.2006"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1994.10.617"},{"key":"e_1_3_2_58_2","first-page":"3","article-title":"Prevalence of HTLV-1 virus infection in Togo (Kozah prefecture and the University Hospital Center of Lome","volume":"93","author":"Balogou AA","year":"2000","unstructured":"Balogou AA, Grunitzky EK, Anani TK, Kowu A, Sadzo-Hetsu A, Nubukpo KA, Dumas M. 2000. Prevalence of HTLV-1 virus infection in Togo (Kozah prefecture and the University Hospital Center of Lome. Bull Soc Pathol Exot 93:3\u20135.","journal-title":"Bull Soc Pathol Exot"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199812010-00018"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006833"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910420509"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06540-11"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir031"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199410000-00021"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199504120-00012"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01249-08"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890390107"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199601010-00014"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.6.1073"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199410000-00021"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.12.004"},{"key":"e_1_3_2_72_2","first-page":"941","article-title":"Nationwide community-based serological survey of HIV-1 and other human retrovirus infections in a central African country","author":"Rwandan HIV Seroprevalence Study Group.","year":"1989","unstructured":"Rwandan HIV Seroprevalence Study Group. 1989. Nationwide community-based serological survey of HIV-1 and other human retrovirus infections in a central African country Lancet i:941\u2013943.","journal-title":"Lancet"},{"key":"e_1_3_2_73_2","first-page":"1146","article-title":"Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City","volume":"49","author":"Gudo ES","year":"2009","unstructured":"Gudo ES, Abreu CM, Mussa T, Augusto AD, Otsuki K, Chambo E, Amade N, Tanuri A, Ferreira OC, Jani IV, Grp HMS, HTLV in Mozambique Study Group. 2009. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City. Mozambique Transfusion 49:1146\u20131150.","journal-title":"Mozambique Transfusion"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2009.0269"},{"key":"e_1_3_2_75_2","first-page":"65","article-title":"HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study","volume":"42","author":"van der Ryst E","year":"1996","unstructured":"van der Ryst E, Joubert G, Smith MS, Terblanche M, Mollentze F, Pretorius AM. 1996. HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study. Cent Afr J Med 42:65\u201368.","journal-title":"Cent Afr J Med"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12778"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit497"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1086\/315139"},{"key":"e_1_3_2_79_2","first-page":"89","article-title":"Human T-cell lymphotropic virus infection among blood donors in south Florida","volume":"4","author":"Parks WP","year":"1991","unstructured":"Parks WP, Lenes BA, Tomasulo PA, Schiff ER, Parks ES, Shaw GM, Lee H, Yan HQ, Lai SH, Hollingsworth CG, Nemo GJ, Mosley JW. 1991. Human T-cell lymphotropic virus infection among blood donors in south Florida. J Acquir Immune Defic Syndr Hum Retrovirol 4:89\u201396.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)93126-T"},{"key":"e_1_3_2_81_2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/tme.12057","article-title":"The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors","volume":"23","author":"O\u2019Brien SF","year":"2013","unstructured":"O\u2019Brien SF, Goldman M, Scalia V, Yi QL, Fan W, Xi G, Dines IR, Fearon MA. 2013. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors. Transfus Med 23:358\u2013366.","journal-title":"Transfus Med"},{"key":"e_1_3_2_82_2","first-page":"383","article-title":"Lymphotropic viruses type I and II in pregnant women in Yucatan","volume":"48","author":"Gongora-Biachi RA","year":"1996","unstructured":"Gongora-Biachi RA, Gonzalez-Martinez P, Castro-Sansores C, Vivas-Rosel ML, Gasque-Lopez F, Garrido-Hadad E. 1996. Lymphotropic viruses type I and II in pregnant women in Yucatan. Rev Invest Clin 48:383\u2013384","journal-title":"Rev Invest Clin"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1993.tb02516.x"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171303"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0368-2315(04)96307-7"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<331::AID-IJC8>3.0.CO;2-W"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2005.73.560"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073978"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.10.005"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.11.2999-3003.1995"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1590\/s0036-46652012000300002"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25231"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200104150-00016"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200312150-00013"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003146"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1590\/s0037-86822012005000007"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1590\/s0037-86822012000200004"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1590\/s0037-86822009000100007"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0037-86822004000100008"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2018.11.003"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.7705\/biomedica.v38i0.3417"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1201-9712(03)90009-9"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1997.56.561"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.16-0014"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1990.42.374"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2012-050594"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1159\/000462650"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1020-49892003000200012"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006304"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39101145.x"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<330::AID-IJC3>3.0.CO;2-2"},{"key":"e_1_3_2_112_2","first-page":"308","article-title":"A seroprevalence study of the anti-HIV antibodies in a Haitian rural population","volume":"82","author":"Schill H","year":"1989","unstructured":"Schill H, Bruneau B, Lepage B, Humeau O, Grimault C, Tampreau V, Devaucouleurs AB, Buisson Y. 1989. A seroprevalence study of the anti-HIV antibodies in a Haitian rural population. Bull Soc Pathol Exotique 82:308\u2013315.","journal-title":"Bull Soc Pathol Exotique"},{"key":"e_1_3_2_113_2","first-page":"717","article-title":"Antibodies to HTLV-I in pregnant women from West Africa, Martinique, and of foreign origin living in France","volume":"172","author":"Denis F","year":"1988","unstructured":"Denis F, Verdier M, Chout R. 1988. Antibodies to HTLV-I in pregnant women from West Africa, Martinique, and of foreign origin living in France. Bull Acad Natl Med 172:717\u2013722.","journal-title":"Bull Acad Natl Med"},{"key":"e_1_3_2_114_2","first-page":"23","article-title":"Prevalence of viral and bacterial sexually transmitted pathogens in Jamaican pregnant women","volume":"47","author":"Dowe G","year":"1998","unstructured":"Dowe G, King SD, Smikle MF, Wynter HH, Chout R, Klaskala W. 1998. Prevalence of viral and bacterial sexually transmitted pathogens in Jamaican pregnant women. West Indian Med J 47:23\u201325.","journal-title":"West Indian Med J"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1086\/506365"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.61.598"},{"key":"e_1_3_2_117_2","first-page":"1162","article-title":"Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) in Jamaica: association with antibodies to envelope glycoprotein (gp46) epitopes","volume":"6","author":"Wiktor SZ","year":"1993","unstructured":"Wiktor SZ, Pate EJ, Murphy EL, Palker TJ, Champegnie E, Ramlal A, Cranston B, Hanchard B, Blattner WA. 1993. Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) in Jamaica: association with antibodies to envelope glycoprotein (gp46) epitopes. J Acquir Immune Defic Syndr (1988) 6:1162\u20131167.","journal-title":"J Acquir Immune Defic Syndr (1988)"},{"key":"e_1_3_2_118_2","first-page":"245","article-title":"Prevalance of HTLV I\/II infection in Thai blood donors","volume":"1","author":"Oota SO","year":"2015","unstructured":"Oota SO. 2015. Prevalance of HTLV I\/II infection in Thai blood donors. Vox Sang 1:245.","journal-title":"Vox Sang"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1159\/000025027"},{"key":"e_1_3_2_120_2","first-page":"S102","article-title":"Seroepidemiology of HTLV-I infection in northeast Thailand: a four year surveillance","volume":"80","author":"Urwijitaroon Y","year":"1997","unstructured":"Urwijitaroon Y, Barusrux S, Puapairoj C, Romphruk A, Khampeera P. 1997. Seroepidemiology of HTLV-I infection in northeast Thailand: a four year surveillance. J Med Assoc Thai 80(Suppl 1):S102\u2013S105.","journal-title":"J Med Assoc Thai"},{"key":"e_1_3_2_121_2","first-page":"532","article-title":"Is seroprevalence of HTLV-I\/II among blood donors in India relevant?","volume":"49","author":"Kumar H","year":"2006","unstructured":"Kumar H, Gupta PK. 2006. Is seroprevalence of HTLV-I\/II among blood donors in India relevant? Indian J Pathol Microbiol 49:532\u2013534.","journal-title":"Indian J Pathol Microbiol"},{"key":"e_1_3_2_122_2","first-page":"35","article-title":"Human T lymphotropic virus-I (HTLV-I), the causative agent of acute T-cell leukaemia\/lymphoma, is absent among blood donors in Aseer region, Saudi Arabia","volume":"26","author":"Ali A","year":"2014","unstructured":"Ali A. 2014. Human T lymphotropic virus-I (HTLV-I), the causative agent of acute T-cell leukaemia\/lymphoma, is absent among blood donors in Aseer region, Saudi Arabia. J King Abdulaziz Univ Sci 26:35\u201352.","journal-title":"J King Abdulaziz Univ Sci"},{"key":"e_1_3_2_123_2","first-page":"26","article-title":"Prevalence of HBV, HCV, HIV-1, HIV-2, and HTLV-I\/II infections among blood donors in a teaching hospital in the central region of Saudi Arabia","volume":"25","author":"El-Hazmi MM","year":"2004","unstructured":"El-Hazmi MM. 2004. Prevalence of HBV, HCV, HIV-1, HIV-2, and HTLV-I\/II infections among blood donors in a teaching hospital in the central region of Saudi Arabia. Saudi Med J 25:26\u201333.","journal-title":"Saudi Med J"},{"key":"e_1_3_2_124_2","first-page":"137","article-title":"Serologial screening of human T cell lymphotropic virus I and II (HTLV I\/II) in blood banks by immunoblotting and enzyme-immuno assays: to demand or to defeat?","volume":"12","author":"Kawashti MI","year":"2005","unstructured":"Kawashti MI, Hindawi SI, Damanhouri GA, Rowehy NG, Bawazeer MM, Alshawa M. 2005. Serologial screening of human T cell lymphotropic virus I and II (HTLV I\/II) in blood banks by immunoblotting and enzyme-immuno assays: to demand or to defeat? Egypt J Immunol 12:137\u2013142.","journal-title":"Egypt J Immunol"},{"key":"e_1_3_2_125_2","first-page":"549","article-title":"Seroprevalence of anti-Treponema pallidum antibodies (syphilis) in blood donors in the southern area of Saudi Arabia","volume":"6","author":"Kilany M","year":"2015","unstructured":"Kilany M, Bin Dajem SM, Ibrahim YM, Alshehri A, Aljeamelani AA, Ibrahim EH. 2015. Seroprevalence of anti-Treponema pallidum antibodies (syphilis) in blood donors in the southern area of Saudi Arabia. Res J Pharm Biol Chem Sci 6:549\u2013556.","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549709019030"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-199911010-00018"},{"key":"e_1_3_2_128_2","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2002.1006"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.8160"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1159\/000026068"},{"key":"e_1_3_2_131_2","article-title":"Seroprevalence of human T-cell lymphotropic virus-1\/2 in blood donors in northern Pakistan: implications for blood donor screening","volume":"25","author":"Niazi SK","year":"2015","unstructured":"Niazi SK, Bhatti FA, Salamat N. 2015. Seroprevalence of human T-cell lymphotropic virus-1\/2 in blood donors in northern Pakistan: implications for blood donor screening. J Coll Physicians Surgeons Pakistan 25.","journal-title":"J Coll Physicians Surgeons Pakistan"},{"key":"e_1_3_2_132_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1988.tb01461.x"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.6.2593-2595.2003"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25192"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.13757"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.154255"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/975135"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10541"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6914.1235"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1995.tb02550.x"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199306000-00013"},{"key":"e_1_3_2_142_2","first-page":"2623","article-title":"Screening of donor blood for viral markers. Anti-HIV, HBsAg and anti-HTLV-I\/II in Denmark 1990\u20131999","volume":"163","author":"Dickmeiss E","year":"2001","unstructured":"Dickmeiss E, Christiansen AH, Smith E. 2001. Screening of donor blood for viral markers. Anti-HIV, HBsAg and anti-HTLV-I\/II in Denmark 1990\u20131999. Ugeskr Laeger 163:2623\u20132628. (In Swedish.)","journal-title":"Ugeskr Laeger"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2012.689847"},{"key":"e_1_3_2_144_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2001.00102.x"},{"key":"e_1_3_2_145_2","first-page":"579","article-title":"Investigation of anti-HTLV I\/II seroprevalence in healthy blood donors in Izmir region, Turkey","volume":"44","author":"Sert\u00f6z R","year":"2010","unstructured":"Sert\u00f6z R, Turhan A, Bozkurt H, Saml\u0131o\u011flu P, De\u011firmenci A, Ayd\u0131nok Y, Erensoy S. 2010. Investigation of anti-HTLV I\/II seroprevalence in healthy blood donors in Izmir region, Turkey. Mikrobiyol Bul 44:579\u2013584. (In Turkish.)","journal-title":"Mikrobiyol Bul"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1507.080796"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00569.x"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910470128"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910430204"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1994.tb01297.x"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<488::AID-IJC2>3.0.CO;2-Q"},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200501010-00018"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1258\/095646206778145541"},{"key":"e_1_3_2_154_2","first-page":"23","article-title":"Seroprevalence of human T cell leukaemia\/lymphoma virus type I (HTLV-I) in pregnant women, patients attending venereological outpatient services and intravenous drug users from Slovenia","volume":"44","author":"Poljak M","year":"1998","unstructured":"Poljak M, Bednarik J, Rednak K, Seme K, Kristancic L, Celan-Lucu B. 1998. Seroprevalence of human T cell leukaemia\/lymphoma virus type I (HTLV-I) in pregnant women, patients attending venereological outpatient services and intravenous drug users from Slovenia. Folia Biol 44:23\u201325.","journal-title":"Folia Biol"},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.76.5.366"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2016.05.022"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7248.1497"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01719953"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92681-7"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006601"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-9-71"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890320309"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb137693.x"},{"key":"e_1_3_2_164_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02982070"},{"key":"e_1_3_2_165_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066795"},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20405"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003685"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.1999.40.2.173"},{"key":"e_1_3_2_169_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21260"},{"key":"e_1_3_2_170_2","first-page":"250","article-title":"Seroepidemiology of human T-cell leukemia virus type I in the Republic of Korea","volume":"77","author":"Lee SY","year":"1986","unstructured":"Lee SY, Yamaguchi K, Takatsuki K, Kim BK, Park S, Lee M. 1986. Seroepidemiology of human T-cell leukemia virus type I in the Republic of Korea. Jpn J Cancer Res 77:250\u2013254.","journal-title":"Jpn J Cancer Res"},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32192116444.x"},{"key":"e_1_3_2_172_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910350304"},{"key":"e_1_3_2_173_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19960301)65:5<569::AID-IJC3>3.0.CO;2-0"},{"key":"e_1_3_2_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(99)00087-6"},{"key":"e_1_3_2_175_2","article-title":"Seroepidemiology of human T-cell lymphotropic virus type I infection in Taiwan","author":"Wang CH","year":"1988","unstructured":"Wang CH, Chen CJ, Hu CY, You SL, Chu CT, Chou MJ, Essex M, Blattner WA, Liu CH, Yang CS. 1988. Seroepidemiology of human T-cell lymphotropic virus type I infection in Taiwan. Cancer Res.","journal-title":"Cancer Res"},{"key":"e_1_3_2_176_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1401"},{"key":"e_1_3_2_177_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-016-3366-5"},{"key":"e_1_3_2_178_2","first-page":"35","article-title":"Investigation of human cytomegalovirus and human T lymphotropic virus infection of voluntary blood donors in the Beijing area","volume":"30","author":"Zhang W","year":"2015","unstructured":"Zhang W, Guo J, Li T, Zhang W, Guo C, Song Y, Che J, Zhang Y, Li M. 2015. Investigation of human cytomegalovirus and human T lymphotropic virus infection of voluntary blood donors in the Beijing area. J Modern Lab Med 30:35\u201338.","journal-title":"J Modern Lab Med"},{"key":"e_1_3_2_179_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910450206"},{"key":"e_1_3_2_180_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70081-6"},{"key":"e_1_3_2_181_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006722"},{"key":"e_1_3_2_182_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.3.1124"},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.2.1015-1023.1993"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.2.1317-1333.1997"},{"key":"e_1_3_2_185_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00091-08"},{"key":"e_1_3_2_186_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-016-0249-x"},{"key":"e_1_3_2_187_2","doi-asserted-by":"publisher","DOI":"10.1159\/000219384"},{"key":"e_1_3_2_188_2","doi-asserted-by":"publisher","DOI":"10.1086\/428625"},{"key":"e_1_3_2_189_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1715724115"},{"key":"e_1_3_2_190_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008164"},{"key":"e_1_3_2_191_2","doi-asserted-by":"publisher","DOI":"10.3390\/v8060161"},{"key":"e_1_3_2_192_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75250"},{"key":"e_1_3_2_193_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2016.08.012"},{"key":"e_1_3_2_194_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.12"},{"key":"e_1_3_2_195_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30328-5"},{"key":"e_1_3_2_196_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910400607"},{"key":"e_1_3_2_197_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199606010-00013"},{"key":"e_1_3_2_198_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2008.01.017"},{"key":"e_1_3_2_199_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00391703"},{"key":"e_1_3_2_200_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.2.268"},{"key":"e_1_3_2_201_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00659-17"},{"key":"e_1_3_2_202_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6872-5_1"},{"key":"e_1_3_2_203_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46652007000600005"},{"key":"e_1_3_2_204_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.2.257"},{"key":"e_1_3_2_205_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.11.4049-4057.2000"},{"key":"e_1_3_2_206_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.1.1.11-15.1994"},{"key":"e_1_3_2_207_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890440119"},{"key":"e_1_3_2_208_2","first-page":"736","article-title":"Licensure of screening tests for antibody to human T-lymphotropic virus type I","volume":"37","author":"Centers for Disease Control.","year":"1988","unstructured":"Centers for Disease Control. 1988. Licensure of screening tests for antibody to human T-lymphotropic virus type I. MMWR Morb Mortal Wkly Rep 37:736\u2013740.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_209_2","first-page":"1","article-title":"Recommendations for counseling persons infected with human T-lymphotrophic virus, types I and II","volume":"42","author":"Centers for Disease Control and Prevention\/U.S. Public Health Service Working Group.","year":"1993","unstructured":"Centers for Disease Control and Prevention\/U.S. Public Health Service Working Group. 1993. Recommendations for counseling persons infected with human T-lymphotrophic virus, types I and II. MMWR Recomm Rep 42:1\u201313.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_2_210_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.341095026973.x"},{"key":"e_1_3_2_211_2","first-page":"68","article-title":"Seroepidemiology of the human T-cell leukaemia\/lymphoma viruses in Europe","volume":"13","author":"HTLV European Research Network.","year":"1996","unstructured":"HTLV European Research Network. 1996. Seroepidemiology of the human T-cell leukaemia\/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 13:68\u201377.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"e_1_3_2_212_2","doi-asserted-by":"publisher","DOI":"10.1086\/596206"},{"key":"e_1_3_2_213_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-2-30"},{"key":"e_1_3_2_214_2","first-page":"1363","article-title":"Evaluation of specificity of EIA kit (ED-007)","volume":"38","author":"Nishimura Y","year":"1990","unstructured":"Nishimura Y, Fukuoka N, Fukuyoshi Y, Matsuo Y, Yamaguchi K, Takatsuki K. 1990. Evaluation of specificity of EIA kit (ED-007). Rinsho Byori 38:1363\u20131367.","journal-title":"Rinsho Byori"},{"key":"e_1_3_2_215_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2011.02.018"},{"key":"e_1_3_2_216_2","doi-asserted-by":"publisher","DOI":"10.1101\/364570"},{"key":"e_1_3_2_217_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.2005.00698.x"},{"key":"e_1_3_2_218_2","doi-asserted-by":"publisher","DOI":"10.1086\/508899"},{"key":"e_1_3_2_219_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23227"},{"key":"e_1_3_2_220_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.22087"},{"key":"e_1_3_2_221_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00138-5"},{"key":"e_1_3_2_222_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.05.022"},{"key":"e_1_3_2_223_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2015.12.001"},{"key":"e_1_3_2_224_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00063-09"},{"key":"e_1_3_2_225_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/29.6.1076"},{"key":"e_1_3_2_226_2","unstructured":"Itabashi K. 2016. HTLV-1 Boshikansen Yobo Taisaku Manyuaru-HTLV-1. https:\/\/www.mhlw.go.jp\/bunya\/kodomo\/boshi-hoken16\/dl\/06.pdf."},{"key":"e_1_3_2_227_2","unstructured":"Ministry of Health Brazil. 2013. Guia De Manejo Clinico Da Infeccao Pelo HTLV. http:\/\/www.sierj.org.br\/artigos\/htlv_manual_final_pdf_25082.pdf."},{"key":"e_1_3_2_228_2","unstructured":"Ministry of Health Brazil. 2013. Manejo clinico HTLV [Clinical management of HTLV]. https:\/\/prefeitura.pbh.gov.br\/sites\/default\/files\/estrutura-de-governo\/saude\/2018\/publicacaoes-da-vigilancia-em-saude\/manejo_clinico_HTLV.PDF. Accessed 3 November 2021."},{"key":"e_1_3_2_229_2","unstructured":"Ministry of Health Chile. 2018. Patient care protocol with HTLV-1. https:\/\/diprece.minsal.cl\/programas-de-salud\/programas-enfermedades-transmisibles\/virus-linfotropico-humano-de-celulas-t-tipo-1-htlv-1\/. Accessed 3 November 2021."},{"key":"e_1_3_2_230_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu227"},{"key":"e_1_3_2_231_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910450534"},{"key":"e_1_3_2_232_2","first-page":"103","article-title":"Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers","volume":"75","author":"Kinoshita K","year":"1984","unstructured":"Kinoshita K, Hino S, Amagaski T, Ikeda S, Yamada Y, Suzuyama J, Momita S, Toriya K, Kamihira S, Ichimaru M. 1984. Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Gann 75:103\u2013105.","journal-title":"Gann"},{"key":"e_1_3_2_233_2","first-page":"474","article-title":"Mother-to-child transmission of human T-cell leukemia virus type I","volume":"76","author":"Hino S","year":"1985","unstructured":"Hino S, Yamaguchi K, Katamine S, Sugiyama H, Amagasaki T, Kinoshita K, Yoshida Y, Doi H, Tsuji Y, Miyamoto T. 1985. Mother-to-child transmission of human T-cell leukemia virus type I. Jpn J Cancer Res 76:474\u2013480.","journal-title":"Jpn J Cancer Res"},{"key":"e_1_3_2_234_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91775-P"},{"key":"e_1_3_2_235_2","doi-asserted-by":"publisher","DOI":"10.1086\/423941"},{"key":"e_1_3_2_236_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.86.1.11"},{"key":"e_1_3_2_237_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92613-2"},{"key":"e_1_3_2_238_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199609)50:1<42::AID-JMV9>3.0.CO;2-T"},{"key":"e_1_3_2_239_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piu070"},{"key":"e_1_3_2_240_2","first-page":"37","article-title":"Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding","volume":"1","author":"Wiktor SZ","year":"1997","unstructured":"Wiktor SZ, Pate EJ, Rosenberg PS, Barnett M, Palmer P, Medeiros D, Maloney EM, Blattner WA. 1997. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol 1:37\u201344.","journal-title":"J Hum Virol"},{"key":"e_1_3_2_241_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/21.5.989"},{"key":"e_1_3_2_242_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910490508"},{"key":"e_1_3_2_243_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.1992.tb00333.x"},{"key":"e_1_3_2_244_2","first-page":"60","article-title":"Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I","volume":"11","author":"Takezaki T","year":"1997","unstructured":"Takezaki T, Tajima K, Ito M, Ito SI, Kinoshita KI, Tachibana K, Matsushita Y. 1997. Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. Leukemia 11:60\u201362.","journal-title":"Leukemia"},{"key":"e_1_3_2_245_2","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.87.152"},{"key":"e_1_3_2_246_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0368-2315(04)96307-7"},{"key":"e_1_3_2_247_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-8-S1-A72"},{"key":"e_1_3_2_248_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990909)82:6<832::AID-IJC11>3.0.CO;2-P"},{"key":"e_1_3_2_249_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25939-y"},{"key":"e_1_3_2_250_2","doi-asserted-by":"publisher","DOI":"10.1086\/498910"},{"key":"e_1_3_2_251_2","doi-asserted-by":"publisher","DOI":"10.1086\/340537"},{"key":"e_1_3_2_252_2","doi-asserted-by":"publisher","DOI":"10.1086\/345364"},{"key":"e_1_3_2_253_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/154.5.851"},{"key":"e_1_3_2_254_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.1.57"},{"key":"e_1_3_2_255_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199606010-00014"},{"key":"e_1_3_2_256_2","first-page":"269","article-title":"Seroepidemiological follow-up of sexual partners of HTLV-I seropositive individuals in Cuba","volume":"61","author":"Diaz TH","year":"2009","unstructured":"Diaz TH, Nibot SC, Cruz SO, Blanco de Armas M, Sanchez RJ, Lubian CA. 2009. Seroepidemiological follow-up of sexual partners of HTLV-I seropositive individuals in Cuba. Seguimiento Seroepidemiologico de Contactos Sexuales de Individuos Seropositivos al HTLV-I en Cuba 61:269\u2013274.","journal-title":"Seguimiento Seroepidemiologico de Contactos Sexuales de Individuos Seropositivos al HTLV-I en Cuba"},{"key":"e_1_3_2_257_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(96)90107-8"},{"key":"e_1_3_2_258_2","doi-asserted-by":"publisher","DOI":"10.1086\/429410"},{"key":"e_1_3_2_259_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890380110"},{"key":"e_1_3_2_260_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/141.4.305"},{"key":"e_1_3_2_261_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33793325055.x"},{"key":"e_1_3_2_262_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-7-555"},{"key":"e_1_3_2_263_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000221680.52563.d5"},{"key":"e_1_3_2_264_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871001)60:7<1474::AID-CNCR2820600712>3.0.CO;2-Y"},{"key":"e_1_3_2_265_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830200205"},{"key":"e_1_3_2_266_2","first-page":"764","article-title":"Human T-cell lymphotropic virus type I infection in neonates","volume":"141","author":"Hara T","year":"1987","unstructured":"Hara T, Takahashi Y, Sonoda S, Kusuhara K, Ueda K. 1987. Human T-cell lymphotropic virus type I infection in neonates. Am J Dis Child 141:764\u2013765.","journal-title":"Am J Dis Child"},{"key":"e_1_3_2_267_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34694295061.x"},{"key":"e_1_3_2_268_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1809779"},{"key":"e_1_3_2_269_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910510609"},{"key":"e_1_3_2_270_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33193142303.x"},{"key":"e_1_3_2_271_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24938"},{"key":"e_1_3_2_272_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30402-5"},{"key":"e_1_3_2_273_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199209053580"},{"key":"e_1_3_2_274_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1998.tb00631.x"},{"key":"e_1_3_2_275_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:CACO.0000003853.82298.96"},{"key":"e_1_3_2_276_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2006.00212.x"},{"key":"e_1_3_2_277_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-257410"},{"key":"e_1_3_2_278_2","volume-title":"IARC monographs on the evaluation of carcinogenic risks to humans: human immunodeficiency viruses and human T-cell lymphotropic viruses.","author":"IARC Working Group.","year":"1996","unstructured":"IARC Working Group. 1996. IARC monographs on the evaluation of carcinogenic risks to humans: human immunodeficiency viruses and human T-cell lymphotropic viruses. World Health Organization, London, United Kingdom."},{"key":"e_1_3_2_279_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"e_1_3_2_280_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-632489"},{"key":"e_1_3_2_281_2","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13398"},{"key":"e_1_3_2_282_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30488-7"},{"key":"e_1_3_2_283_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19991029)83:3%3C291::AID-IJC1>3.0.CO;2-P"},{"key":"e_1_3_2_284_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199600001-00005"},{"key":"e_1_3_2_285_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25147"},{"key":"e_1_3_2_286_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B"},{"key":"e_1_3_2_287_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.964700"},{"key":"e_1_3_2_288_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)92359-2"},{"key":"e_1_3_2_289_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21738"},{"key":"e_1_3_2_290_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910430214"},{"key":"e_1_3_2_291_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-016-0784-8"},{"key":"e_1_3_2_292_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.069476"},{"key":"e_1_3_2_293_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.03.012"},{"key":"e_1_3_2_294_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001628"},{"key":"e_1_3_2_295_2","first-page":"226","article-title":"Incidence of adult T-cell leukemia\/lymphoma among human T-lymphotropic virus type I carriers in Saga","volume":"49","author":"Tokudome S","year":"1989","unstructured":"Tokudome S, Tokunaga O, Shimamoto Y, Miyamoto Y, Sumida I, Kikuchi M, Takeshita M, Ikeda T, Fujiwara K, Yoshihara M. 1989. Incidence of adult T-cell leukemia\/lymphoma among human T-lymphotropic virus type I carriers in Saga. Cancer Res 49:226\u2013228.","journal-title":"Cancer Res"},{"key":"e_1_3_2_296_2","doi-asserted-by":"publisher","DOI":"10.1086\/315088"},{"key":"e_1_3_2_297_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1019511224501"},{"key":"e_1_3_2_298_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.10.3557.422k09_3557_3561"},{"key":"e_1_3_2_299_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203870"},{"key":"e_1_3_2_300_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922201300343735"},{"key":"e_1_3_2_301_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2006.22.931"},{"key":"e_1_3_2_302_2","volume-title":"Scientific Group on HTLV-I Infections and Associated Diseases, Kagoshima, Japan, 10\u201315 December 1988: report.","author":"World Health Organization\/Regional Office for the Western Pacific.","year":"1988","unstructured":"World Health Organization\/Regional Office for the Western Pacific. 1988. Scientific Group on HTLV-I Infections and Associated Diseases, Kagoshima, Japan, 10\u201315 December 1988: report. WHO Regional Office for the Western Pacific, Manila, Philippines."},{"key":"e_1_3_2_303_2","first-page":"147","article-title":"A neuropathic syndrome of uncertain origin; review of 100 cases","volume":"5","author":"Cruickshank EK","year":"1956","unstructured":"Cruickshank EK. 1956. A neuropathic syndrome of uncertain origin; review of 100 cases. West Indian Med J 5:147\u2013158.","journal-title":"West Indian Med J"},{"key":"e_1_3_2_304_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/87.3.425"},{"key":"e_1_3_2_305_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91298-5"},{"key":"e_1_3_2_306_2","first-page":"1096","article-title":"The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I","volume":"3","author":"Kaplan JE","year":"1990","unstructured":"Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS. 1990. The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 3:1096\u20131101.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_3_2_307_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199802010-00011"},{"key":"e_1_3_2_308_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000096011.92542.DA"},{"key":"e_1_3_2_309_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2013.0086"},{"key":"e_1_3_2_310_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2009005000008"},{"key":"e_1_3_2_311_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2005.05.010"},{"key":"e_1_3_2_312_2","doi-asserted-by":"publisher","DOI":"10.1080\/13550280152403272"},{"key":"e_1_3_2_313_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410290214"},{"key":"e_1_3_2_314_2","doi-asserted-by":"publisher","DOI":"10.3109\/13550289809114225"},{"key":"e_1_3_2_315_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7014-z"},{"key":"e_1_3_2_316_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.11.1560"},{"key":"e_1_3_2_317_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.1999.0422"},{"key":"e_1_3_2_318_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3848"},{"key":"e_1_3_2_319_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01651"},{"key":"e_1_3_2_320_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-321955"},{"key":"e_1_3_2_321_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1413-86702011000600013"},{"key":"e_1_3_2_322_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181b6bba9"},{"key":"e_1_3_2_323_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ229"},{"key":"e_1_3_2_324_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.05.027"},{"key":"e_1_3_2_325_2","first-page":"1","article-title":"Ocular manifestations in patients infected with human T-lymphotropic virus type I","volume":"33","author":"Ohba N","year":"1989","unstructured":"Ohba N, Matsumoto M, Sameshima M, Kabayama Y, Nakao K, Unoki K, Uehara F, Kawano K, Maruyama I, Osame M. 1989. Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol 33:1\u201312.","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_3_2_326_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1992.tb00092.x"},{"key":"e_1_3_2_327_2","first-page":"162","article-title":"A multicenter case-control study of HTLV-I associated uveitis","volume":"38","author":"Ohba N","year":"1994","unstructured":"Ohba N, Nakao K, Isashiki Y, Osame M, Sonoda S, Yashiki S, Yamaguchi K, Tajima K, Study Group for HTLV-I Associated Ocular Diseases. 1994. A multicenter case-control study of HTLV-I associated uveitis. Jpn J Ophthalmol 38:162\u2013167.","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_3_2_328_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.4.943"},{"key":"e_1_3_2_329_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117735"},{"key":"e_1_3_2_330_2","first-page":"676","article-title":"Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis: accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids","volume":"38","author":"Ono A","year":"1997","unstructured":"Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T. 1997. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis: accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids. Invest Ophthalmol Vis Sci 38:676\u2013689.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_331_2","first-page":"472","article-title":"Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I","volume":"33","author":"Nakao K","year":"1989","unstructured":"Nakao K, Ohba N, Matsumoto M. 1989. Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol 33:472\u2013481.","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_3_2_332_2","first-page":"168","article-title":"Clinical features of HTLV-I associated uveitis determined in multicenter collaborative study","volume":"38","author":"Ohba N","year":"1994","unstructured":"Ohba N, Nakao K, Isashiki Y, Kaminagayoshi T, Sonoda S, Yashiki S, Osame M, Study Group for HTLV-I Associated Ocular Diseases. 1994. Clinical features of HTLV-I associated uveitis determined in multicenter collaborative study. Jpn J Ophthalmol 38:168\u2013174.","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_3_2_333_2","doi-asserted-by":"publisher","DOI":"10.1076\/ocii.8.4.235.6454"},{"key":"e_1_3_2_334_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5155(99)00099-4"},{"key":"e_1_3_2_335_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-012-0158-z"},{"key":"e_1_3_2_336_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1212-4"},{"key":"e_1_3_2_337_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.79.3.270"},{"key":"e_1_3_2_338_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92896-P"},{"key":"e_1_3_2_339_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1966.tb12181.x"},{"key":"e_1_3_2_340_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.4.439"},{"key":"e_1_3_2_341_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis273"},{"key":"e_1_3_2_342_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03869.x"},{"key":"e_1_3_2_343_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-13-11"},{"key":"e_1_3_2_344_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200006000-00014"},{"key":"e_1_3_2_345_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92413-V"},{"key":"e_1_3_2_346_2","first-page":"34","article-title":"Tropical spastic paraparesis occurring in HTLV-1 associated infective dermatitis: report of two cases","volume":"44","author":"LaGrenade L","year":"1995","unstructured":"LaGrenade L, Morgan C, Carberry C, Hanchard B, Fletcher V, Gray R, Cranston B, Rodgers-Johnson P, Manns A. 1995. Tropical spastic paraparesis occurring in HTLV-1 associated infective dermatitis: report of two cases. West Indian Med J 44:34\u201335.","journal-title":"West Indian Med J"},{"key":"e_1_3_2_347_2","doi-asserted-by":"publisher","DOI":"10.1086\/432058"},{"key":"e_1_3_2_348_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910570227"},{"key":"e_1_3_2_349_2","doi-asserted-by":"publisher","DOI":"10.1086\/524695"},{"key":"e_1_3_2_350_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.2.e136"},{"key":"e_1_3_2_351_2","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmx039"},{"key":"e_1_3_2_352_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy289"},{"key":"e_1_3_2_353_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05834.x"},{"key":"e_1_3_2_354_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91362-6"},{"key":"e_1_3_2_355_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2012.03.020"},{"key":"e_1_3_2_356_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2402050886"},{"key":"e_1_3_2_357_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006281"},{"key":"e_1_3_2_358_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu023"},{"key":"e_1_3_2_359_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1002-0"},{"key":"e_1_3_2_360_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-021-00549-1"},{"key":"e_1_3_2_361_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1428-z"},{"key":"e_1_3_2_362_2","doi-asserted-by":"publisher","DOI":"10.1086\/514143"},{"key":"e_1_3_2_363_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.3.584"},{"key":"e_1_3_2_364_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.32.623"},{"key":"e_1_3_2_365_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000174252.73516.7a"},{"key":"e_1_3_2_366_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31817efb83"},{"key":"e_1_3_2_367_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-199"},{"key":"e_1_3_2_368_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.1.208-217.2004"},{"key":"e_1_3_2_369_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.60.146"},{"key":"e_1_3_2_370_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000456"},{"key":"e_1_3_2_371_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0141-9838.2004.00726.x"},{"key":"e_1_3_2_372_2","first-page":"CD007745","article-title":"Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection","volume":"2016","author":"Henriquez-Camacho C","year":"2016","unstructured":"Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC, Jr, Terashima A, Samalvides F, P\u00e9rez-Molina JA, Plana MN. 2016. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev 2016:CD007745.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_373_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-1-4"},{"key":"e_1_3_2_374_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181cc5481"},{"key":"e_1_3_2_375_2","doi-asserted-by":"publisher","DOI":"10.1086\/379780"},{"key":"e_1_3_2_376_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1994.tb02087.x"},{"key":"e_1_3_2_377_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-4-85"},{"key":"e_1_3_2_378_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029026"},{"key":"e_1_3_2_379_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<293::AID-IJC1>3.0.CO;2-Q"},{"key":"e_1_3_2_380_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(92)90215-7"},{"key":"e_1_3_2_381_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.2428"},{"key":"e_1_3_2_382_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00501"},{"key":"e_1_3_2_383_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506293322603"},{"key":"e_1_3_2_384_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109057927"},{"key":"e_1_3_2_385_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200195"},{"key":"e_1_3_2_386_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.0669"},{"key":"e_1_3_2_387_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.5578"},{"key":"e_1_3_2_388_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930401)71:7<2217::AID-CNCR2820710709>3.0.CO;2-8"},{"key":"e_1_3_2_389_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.394"},{"key":"e_1_3_2_390_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509059624"},{"key":"e_1_3_2_391_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063"},{"key":"e_1_3_2_392_2","first-page":"1263","article-title":"Menogaril (TUT-7) late phase II study for malignant lymphoma, adult T-cell leukemia and lymphoma (ATLL)","volume":"24","author":"Taguchi T","year":"1997","unstructured":"Taguchi T, Ohta K, Hotta T, Shirakawa S, Masaoka T, Kimura I. 1997. Menogaril (TUT-7) late phase II study for malignant lymphoma, adult T-cell leukemia and lymphoma (ATLL). Gan to Kagaku Ryoho 24:1263\u20131271.","journal-title":"Gan to Kagaku Ryoho"},{"key":"e_1_3_2_393_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02737.x"},{"key":"e_1_3_2_394_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02983215"},{"key":"e_1_3_2_395_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.9958"},{"key":"e_1_3_2_396_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01411.x"},{"key":"e_1_3_2_397_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.12.004"},{"key":"e_1_3_2_398_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3472"},{"key":"e_1_3_2_399_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13338"},{"key":"e_1_3_2_400_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.205096"},{"key":"e_1_3_2_401_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.7732"},{"key":"e_1_3_2_402_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702731"},{"key":"e_1_3_2_403_2","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.07070"},{"key":"e_1_3_2_404_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.03.010"},{"key":"e_1_3_2_405_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.92"},{"key":"e_1_3_2_406_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.12.020"},{"key":"e_1_3_2_407_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.11.318"},{"key":"e_1_3_2_408_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.154"},{"key":"e_1_3_2_409_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15123"},{"key":"e_1_3_2_410_2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000832"},{"key":"e_1_3_2_411_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.2.173-a"},{"key":"e_1_3_2_412_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X1993000300005"},{"key":"e_1_3_2_413_2","doi-asserted-by":"publisher","DOI":"10.3109\/13550289609146899"},{"key":"e_1_3_2_414_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.01.004"},{"key":"e_1_3_2_415_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152557"},{"key":"e_1_3_2_416_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0533-z"},{"key":"e_1_3_2_417_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-11-S1-P30"},{"key":"e_1_3_2_418_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704827"},{"key":"e_1_3_2_419_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2655084"},{"key":"e_1_3_2_420_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.2.252"},{"key":"e_1_3_2_421_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00145387"},{"key":"e_1_3_2_422_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199708150-00009"},{"key":"e_1_3_2_423_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.33.7.1735-1738.1995"},{"key":"e_1_3_2_424_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199600001-00031"},{"key":"e_1_3_2_425_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1001.020714"},{"key":"e_1_3_2_426_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.13.1485"},{"key":"e_1_3_2_427_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-3-1"},{"key":"e_1_3_2_428_2","volume-title":"Weekly Epidemiological Record, number 29.","author":"World Health Organization.","year":"1992","unstructured":"World Health Organization. 1992. Weekly Epidemiological Record, number 29. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_429_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.6.1193"},{"key":"e_1_3_2_430_2","first-page":"1971","article-title":"Prevention of human T cell lymphotropic virus type I infection in Japanese macaques by passive immunization","volume":"10","author":"Murata N","year":"1996","unstructured":"Murata N, Hakoda E, Machida H, Ikezoe T, Sawada T, Hoshino H, Miyoshi I. 1996. Prevention of human T cell lymphotropic virus type I infection in Japanese macaques by passive immunization. Leukemia 10:1971\u20131974.","journal-title":"Leukemia"},{"key":"e_1_3_2_431_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1995.11.307"},{"key":"e_1_3_2_432_2","first-page":"5687S","article-title":"Subunit vaccine protects Macaca nemestrina (pig-tailed macaque) against simian T-cell lymphotropic virus type I challenge","volume":"50","author":"Dezzutti CS","year":"1990","unstructured":"Dezzutti CS, Frazier DE, Huff LY, Stromberg PC, Olsen RG. 1990. Subunit vaccine protects Macaca nemestrina (pig-tailed macaque) against simian T-cell lymphotropic virus type I challenge. Cancer Res 50:5687S\u20135691S.","journal-title":"Cancer Res"},{"key":"e_1_3_2_433_2","doi-asserted-by":"publisher","DOI":"10.3390\/v3071210"},{"key":"e_1_3_2_434_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(89)94772-5"},{"key":"e_1_3_2_435_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2004.03.019"},{"key":"e_1_3_2_436_2","first-page":"974","article-title":"Prevention of HTLV-I transmission through the breast milk by a freeze-thawing process","volume":"77","author":"Ando Y","year":"1986","unstructured":"Ando Y, Nakano S, Saito K, Shimamoto I, Ichijo M, Toyama T, Hinuma Y. 1986. Prevention of HTLV-I transmission through the breast milk by a freeze-thawing process. Jpn J Cancer Res 77:974\u2013977.","journal-title":"Jpn J Cancer Res"},{"key":"e_1_3_2_437_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1989.tb02327.x"},{"key":"e_1_3_2_438_2","unstructured":"Ministry of Health Labour and Welfare of Japan. 2010. Revision of the announcement on screening of pregnant women for HTLV-1. (In Japanese.) https:\/\/www.mhlw.go.jp\/stf\/houdou\/2r9852000000thw2.html. Accessed 3 September 2021."},{"key":"e_1_3_2_439_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1020-49892006000100007"},{"key":"e_1_3_2_440_2","volume-title":"Circular DGS\/SP 2 97-785 of 16 December 1997 on the personalized donation of milk from a mother to her hospitalized child and a reminder of the provisions in force concerning breastfeeding.","author":"Director General of Health (J. M\u00e9nard).","year":"1996","unstructured":"Director General of Health (J. M\u00e9nard). 1996. Circular DGS\/SP 2 97-785 of 16 December 1997 on the personalized donation of milk from a mother to her hospitalized child and a reminder of the provisions in force concerning breastfeeding. (In French.) Health Branch Population Health Branch Offices of the Ages of Life and Population, Paris, France. https:\/\/solidarites-sante.gouv.fr\/fichiers\/bo\/1998\/98-03\/a0030114.htm. Accessed 3 November 2021."},{"key":"e_1_3_2_441_2","volume-title":"National Institute for Health and Clinical Excellence: guidance.","author":"Centre for Clinical Practice at NICE.","year":"2010","unstructured":"Centre for Clinical Practice at NICE. 2010. National Institute for Health and Clinical Excellence: guidance. National Institute for Health and Clinical Excellence, London, United Kingdom."},{"key":"e_1_3_2_442_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006913"},{"key":"e_1_3_2_443_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1987.tb02987.x"},{"key":"e_1_3_2_444_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-7-554"},{"key":"e_1_3_2_445_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39101104.x"},{"key":"e_1_3_2_446_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01538.x"},{"key":"e_1_3_2_447_2","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/trf.12105","article-title":"Human T-lymphotropic virus lookback in NHS Blood and Transplant (England) reveals the efficacy of leukoreduction","volume":"53","author":"Hewitt PE","year":"2013","unstructured":"Hewitt PE, Davison K, Howell DR, Taylor GP. 2013. Human T-lymphotropic virus lookback in NHS Blood and Transplant (England) reveals the efficacy of leukoreduction. Transfusion 53:2168\u20132175.","journal-title":"Transfusion"},{"key":"e_1_3_2_448_2","unstructured":"Japanese Red Cross Society. 2017. Blood services. JRC Society Tokyo Japan."},{"key":"e_1_3_2_449_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2008.01136.x"},{"key":"e_1_3_2_450_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12127"},{"key":"e_1_3_2_451_2","unstructured":"U.S. Department of Health and Human Services. 2014. Guidance for HTLV-1 screening and confirmation in potential donors and reporting potential HTLV-1 infection. DHHS Washington DC. https:\/\/optn.transplant.hrsa.gov\/resources\/guidance\/guidance-for-htlv-1-screening-and-confirmation-in-potential-donors-and-reporting-potential-htlv-1-infection\/. Accessed 3 November 2021."},{"key":"e_1_3_2_452_2","volume-title":"Geographical distribution of areas with a high prevalence of HTLV-1 infection.","author":"European Centre for Disease Prevention and Control.","year":"2015","unstructured":"European Centre for Disease Prevention and Control. 2015. Geographical distribution of areas with a high prevalence of HTLV-1 infection. ECDC, Stockholm, Sweden."},{"key":"e_1_3_2_453_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-739433"},{"key":"e_1_3_2_454_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30974-7"},{"key":"e_1_3_2_455_2","unstructured":"Public Health England. 2021. Surveillance methods: HTLV. Public Health England London United Kingdom. https:\/\/webarchive.nationalarchives.gov.uk\/20140714093033\/http:\/\/www.hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/HTLV\/SurveillanceMethods\/. Accessed 3 September 2021."},{"key":"e_1_3_2_456_2","unstructured":"Northern Territory Government of Australia. 2019. Human T lymphotropic virus: HTLV-I. https:\/\/nt.gov.au\/wellbeing\/health-conditions-treatments\/viral\/htlv. Accessed 3 November 2021."},{"key":"e_1_3_2_457_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2004.70.158"},{"key":"e_1_3_2_458_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910400607"},{"key":"e_1_3_2_459_2","first-page":"322","article-title":"Transmission of adult T-cell leukemia retrovirus (HTLV-I) from mother to child: comparison of bottle- with breast-fed babies","volume":"78","author":"Ando Y","year":"1987","unstructured":"Ando Y, Nakano S, Saito K, Shimamoto I, Ichijo M, Toyama T, Hinuma Y. 1987. Transmission of adult T-cell leukemia retrovirus (HTLV-I) from mother to child: comparison of bottle- with breast-fed babies. Jpn J Cancer Res 78:322\u2013324.","journal-title":"Jpn J Cancer Res"},{"key":"e_1_3_2_460_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1993.9.869"},{"key":"e_1_3_2_461_2","doi-asserted-by":"publisher","DOI":"10.1590\/s1020-49892007000900001"},{"key":"e_1_3_2_462_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24745"},{"key":"e_1_3_2_463_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1984.tb00083.x"},{"key":"e_1_3_2_464_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200102010-00015"},{"key":"e_1_3_2_465_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202063260604"},{"key":"e_1_3_2_466_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440010058030"},{"key":"e_1_3_2_467_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2504.180984"},{"key":"e_1_3_2_468_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2510.190484"},{"key":"e_1_3_2_469_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0042-9007.2001.00143.x"},{"key":"e_1_3_2_470_2","volume-title":"Essential safety requirements (ESR): standards for Saudi CBAHI accreditation in hospitals and PHC\u2019s.","author":"Siddiqui A","year":"2002","unstructured":"Siddiqui A. 2002. Essential safety requirements (ESR): standards for Saudi CBAHI accreditation in hospitals and PHC\u2019s. Saudi Central Board for Accreditation of Health Care Institutions (CBAHI), Riyadh, Saudi Arabia."},{"key":"e_1_3_2_471_2","first-page":"82","article-title":"Introduction to iranian blood transfusion organization and blood safety in Iran","volume":"38","author":"Abolghasemi H","year":"2009","unstructured":"Abolghasemi H, Maghsudlu M, Amini Kafi-Abad S, Cheraghali A. 2009. Introduction to iranian blood transfusion organization and blood safety in Iran. Iranian J Publ Health 38:82\u201387.","journal-title":"Iranian J Publ Health"},{"key":"e_1_3_2_472_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.20.30539"},{"key":"e_1_3_2_473_2","unstructured":"Legifrance le Service Public de la Diffusion du Droit. 2018. Public health code: article D1221-6. Legifrance le Service Public de la Diffusion du Droit Paris France. https:\/\/www.legifrance.gouv.fr\/affichCodeArticle.do?idArticle=LEGIARTI000037924559&cidTexte=LEGITEXT000006072665&dateTexte=20181227. Accessed 11 October."},{"key":"e_1_3_2_474_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001527"},{"key":"e_1_3_2_475_2","unstructured":"Government of Spain. 2014. Boletin Oficial Del Estado. Government of Spain Madrid Spain. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/sanidadExterior\/MB\/rd_9_2014.pdf. Accessed 3 November 2021."},{"key":"e_1_3_2_476_2","unstructured":"Ministry of Health Canada. 2014. Guidance document: blood regulations. Ministry of Health Canada Ottowa Ontario Canada. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/biologics-radiopharmaceuticals-genetic-therapies\/applications-submissions\/guidance-documents\/blood-regulations\/guidance-document-blood-regulations-1.html. Accessed 3 November 2021."},{"key":"e_1_3_2_477_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13329"},{"key":"e_1_3_2_478_2","volume-title":"Caribbean regional standards for blood banks and transfusion services","author":"Pan American Health Organization.","year":"2012","unstructured":"Pan American Health Organization. 2012. Caribbean regional standards for blood banks and transfusion services, 2nd ed. Pan American Health Organization, Washington, DC. https:\/\/iris.paho.org\/handle\/10665.2\/3196. Accessed 3 September 2020.","edition":"2"},{"key":"e_1_3_2_479_2","volume-title":"Official Mexican standard NOM-253-SSA1-2012 for the disposal of human blood and its components for therapeutic purposes.","author":"Mexico Ministry of Health.","year":"2012","unstructured":"Mexico Ministry of Health. 2012. Official Mexican standard NOM-253-SSA1-2012 for the disposal of human blood and its components for therapeutic purposes. Center NBt, Mexico City, Mexico."},{"key":"e_1_3_2_480_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46652009000100005"},{"key":"e_1_3_2_481_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12127"},{"key":"e_1_3_2_482_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-6-199303150-00009"},{"key":"e_1_3_2_483_2","unstructured":"Ministry of Health and Social Protection. 2014. Resoluci\u00f3n n\u00famero 000437 de 2014 [Resolution no. 000437 of 2014]. Ministry of Health and Social Protection Bogota Columbia. https:\/\/www.minsalud.gov.co\/Normatividad_Nuevo\/Resoluci%C3%B3n%200437%20de%202014.pdf. Accessed 3 November 2021."},{"key":"e_1_3_2_484_2","first-page":"84","article-title":"Contributions and considerations on infection with human T-lymphotropic viruses type 1 and 2 in Argentina","volume":"21","author":"Mirna M","year":"2013","unstructured":"Mirna M, Biglione CAB. 2013. Contributions and considerations on infection with human T-lymphotropic viruses type 1 and 2 in Argentina. Updates AIDS Infectol 21:84\u201394.","journal-title":"Updates AIDS Infectol"},{"key":"e_1_3_2_485_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2014.07.036"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00078-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00078-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:23:08Z","timestamp":1700266988000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/cmr.00078-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":484,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4,20]]}},"alternative-id":["10.1128\/cmr.00078-21"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00078-21","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"2022-02-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00078-21"}}